New trial tests if operating on Newborns' hearts within 28 days beats waiting months

NCT ID NCT06822400

Recruiting now Disease control Sponsor: Beijing Anzhen Hospital Source: ClinicalTrials.gov ↗

First seen Jun 26, 2026 · Last updated Jun 26, 2026 · Updated 1 time

Summary

This study compares two surgical timings for babies born with Tetralogy of Fallot, a serious heart defect. One group gets corrective surgery within 28 days of birth, the other at the usual 3-6 months. Researchers will track deaths, reoperations, and recovery to see if earlier surgery leads to better outcomes.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: corrective heart surgery
What this could lead to: If early surgery works better, it could improve survival and long-term heart function for babies born with this serious heart defect.
What could go wrong: This is a relatively small trial (160 babies) and results may not apply to all hospitals. Surgery in newborns carries higher risks of complications.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for DOUBLE OUTLET RIGHT VENTRICLE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

double outlet right ventricle pulmonary valve stenosis pulmonic stenosis tetralogy of fallot ventricular septal defect

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

DOUBLE OUTLET RIGHT VENTRICLE PULMONARY STENOSIS TETRALOGY OF FALLOT (TOF) VENTRICULAR SEPTAL DEFECTS (VSD)

Contacts and locations

Locations

Beijing Anzhen Hospital
RECRUITING

Beijing, Beijing Municipality, 100013, China

More trials for these conditions

Other studies related to the condition(s) this trial covers.